Physician profile
William A Elfarr
NPI 1275542144
$3,998.39
in general payments reported to CMS, 2019-2025
32 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $316 · 2021: $367 · 2022: $1,359 · 2023: $703 · 2024: $524 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,596.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $796.12 | 2022-2023 | Urolift |
| Astellas Pharma US INC | $631.75 | 2019-2025 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $300.72 | 2019-2025 | General - Erectile Dysfunction |
| Antares Pharma, INC. | $280.70 | 2022-2025 | Xyosted |
| Sumitomo Pharma America, INC. | $243.39 | 2023 | Gemtesa, Orgovyx |
| Pfizer INC. | $203.08 | 2019-2025 | |
| Procept Biorobotics Corporation | $193.32 | 2019-2025 | Aquabeam System |
| Myovant Sciences INC. | $127.92 | 2021-2022 | |
| Urovant Sciences INC | $122.25 | 2021-2022 | |
| Axonics, INC. | $117.43 | 2020-2023 | Axonics, Bulkamid |
| Coloplast Corp | $115.19 | 2019-2024 | Titan |
| Janssen Biotech, INC. | $88.86 | 2022-2023 | Erleada |
| Abbvie INC. | $84.66 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $66.47 | 2024 | Provenge |
| Tolmar, INC. | $65.99 | 2023-2025 | Eligard, Jatenzo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $64.95 | 2023 | Pylarify |
| Ambu INC. | $64.08 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.60 | 2023-2025 | |
| Amgen INC. | $63.14 | 2020-2021 | |
| Medtronic USA, INC. | $55.37 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $54.67 | 2021-2023 | Xiaflex |
| Endo USA, INC. | $23.64 | 2024 | Xiaflex |
| Ferring Pharmaceuticals INC. | $22.48 | 2019 | |
| Accord Healthcare, INC. | $18.06 | 2022 | |
| Integra Lifesciences Corporation | $17.89 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $17.76 | 2020 | |
| Cook Medical LLC | $17.14 | 2024 | Resonance |
| Blue Earth Diagnostics | $17.11 | 2022 | |
| Urogen Pharma, INC. | $17.02 | 2023 | Jelmyto |
| Convatec INC. | $16.31 | 2024 | |
| Abc Home Medical Supply, INC. | $14.57 | 2025 | |
| Civco Medical Instruments | $12.75 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Elfarr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.